2 results match your criteria: "Shandong University Jinan 250117[Affiliation]"
High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer.
Int J Clin Exp Pathol
May 2018
Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University Jinan 250117, Shandong Province, China.
The purpose of this study was to investigate the association between the expression of programmed cell death ligand 1 (PD-L1) and the survival of patients with small cell lung cancer (SCLC) who had undergone complete resection. Formalin-fixed, paraffin-embedded tumor tissue samples from 61 patients with resected SCLC were stained with an anti-PD-L1 antibody (SP142) by immunohistochemistry (IHC) and scored according to staining intensity and the percentage of tumor cells staining positive for PD-L1. The PD-L1 positive threshold in tumor cells was defined as ≥ 5%.
View Article and Find Full Text PDFMicroRNA-153 expression and prognosis in non-small cell lung cancer.
Int J Clin Exp Pathol
June 2016
Department of Chemotherapy, Qilu Hospital, Shandong University Jinan 250117, Shandong, China.
Article Synopsis
- * The study showed that lower miR-153 expression is associated with more advanced clinical stages, worse lymph node involvement, increased distant metastasis, and poorer differentiation in NSCLC patients.
- * Kaplan-Meier survival analysis suggested that patients with lower miR-153 levels have significantly worse overall survival rates, indicating that it could serve as an independent prognostic factor for NSCLC.